| YEL057C |
Saccharomyces cerevisiae |
|
YEL057C is differentially expressed in 21 experiments [21 up/28 dn]: 4 compound treatments: none [0 up/2 dn], doxycycline [1 up/0 dn], ...; 2 developmental stages: mitotic growth [0 up/1 dn], meiotic development [1 up/0 dn], 14 genotypes, 12 growth conditions, 2 material types and 1 other conditions. |
| YEL057C |
|
|
|
P39983
|
|
|
|
YEL057C
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Wild_type
|
Genotype |
|
|
50% dessication
|
Growth condition |
|
|
Rehydration
|
Growth condition |
|
|
Control
|
Growth condition |
|
|
YPD media
|
Growth condition |
|
|
Dessication
|
Growth condition |
|
|
None
|
Compound treatment |
|
|
YPGal media
|
Growth condition |
|
|
SPII media
|
Growth condition |
|
|
Mitotic growth
|
Developmental stage |
|
|
Meiotic development
|
Developmental stage |
|
|
3 days in YPD + 2% glucose for...
|
Growth condition |
|
|
3 days in YPD (control)
|
Growth condition |
|
|
Nitrogen limited
|
Growth condition |
|
|
Carbon limited
|
Growth condition |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
YPA media
|
Growth condition |
|
|
Doxycycline
|
Compound treatment |
|
|
MATα cdc13-1-int mfa::MFA...
|
Genotype |
|
|
MATα mfa::MFA1pr-HIS3 can...
|
Genotype |
|
|
Commercial dry active yeast
|
Strain or line |
|
|
BY4743
|
Strain or line |
|
|
Ume6 knock-out
|
Genotype |
|
|
UASGAL1-IFH1-13myc-TRP1
|
Genotype |
|
|
IFH1-13myc-TRP1
|
Genotype |
|
|
Lithium chloride
|
Compound treatment |
|
|
Total_RNA
|
Material type |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
Upf1Δ
|
Genotype |
|
|
Methyl methanesulfonate
|
Compound treatment |
|
|
H4delta(2-26)
|
Genotype |
|
|
H2B 30-37 deletion
|
Genotype |
|
|
Abf1-1 hypomorph, homozygous
|
Genotype |
|
|
GAL-ABF1 overexpression transg...
|
Genotype |
|
|
Dcp1::URA3
|
Genotype |
|
|
Polysomal_RNA
|
Material type |
|
|
|
|
|
Processing time: 0.054 secs.